This was supported by Zhou et al. that the association of serum autoantibody positivity and significant fibrosis was restricted to NAFLD patients carrying the PNPLA3 CG or GG genotypes [14]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.